NextPharma Technologies Appoints Three New Senior Team Members
Published: Aug 29, 2012
Andrew brings over 27 years of experience in the pharmaceutical industry, with a strong track record leading manufacturing operations, most recently at Patheon. Pierre has a strong background in sales and marketing in the pharmaceutical industry and joins the team from SkyePharma, having previously spent 14 years at Catalent, where he held various senior positions. Matthew has over ten years of sales and marketing experience in the US pharmaceutical industry and joins NextPharma from Sanofi Pharmaceuticals, where he held various senior positions.
Franck Latrille, Chief Executive Officer, NextPharma, commented: “We are delighted to welcome our three new colleagues to our growing team at NextPharma. This is an exciting time for the company, and we are confident that with the injection of their expertise to the team, we can continue to improve our business offerings.”
Executive Vice President Corporate Development
NextPharma Technologies Holding Limited (www.nextpharma.com)
Tel: +44 (0) 1483 479 120
NextPharma, headquartered in the UK and founded in 2000, is a world class outsourcing partner to the pharmaceutical and biotechnology industry. The company:
• Offers a full range of services from early phase product development, through clinical trial packaging (Phases I through III) to high volume commercial manufacturing. The company is a world leader in pellet technologies and in specialist product manufacturing including hormones, penicillins, and cephalosporins, in addition to providing manufacturing and packaging services for conventional product forms. Additionally, NextPharma offers integrated logistics solutions tailored to meet the needs of the global pharmaceutical industry.
• Operates globally with six product development centres, six manufacturing plants and six temperature controlled storage and distribution sites across Europe (production facilities in France and Germany) and North America, supplying customers in North America, Europe and Japan.
• Has 1,000 employees dedicated to serving over 150 customers worldwide. Its customer base includes many of the world’s leading pharmaceutical, specialty pharma and biotech companies.
About new appointments
Andrew Kelley, Chief Operating Officer, comes to NextPharma with over 27 years of experience in the pharmaceutical industry and with a strong track record leading manufacturing operations in contract manufacturing organisations. Prior to joining NextPharma, Andrew spent over six years with Patheon, where he held senior positions as Vice President Business Development covering Europe and Asia Pacific and Vice President UK and France Operations. Previously, Andrew spent sixteen years with R.P.Scherer/Cardinal Health (now Catalent) in various operations roles, culminating in the position of Vice President European Operations, covering eleven facilities.
Andrew holds a degree in Chemical Engineering and an MBA.
Pierre Delavaud, EVP Sales and Marketing, joins NextPharma with a strong track record in sales, business development and marketing within the pharmaceutical industry. Prior to joining NextPharma, Pierre held executive sales and business development positions at SkyePharma and spent fourteen years with the Catalent group (and former companies), where he held various senior positions, including Vice President Sales and Business Development Global Pharmaceutical Softgels, Vice President Sales and Marketing Pharmaceutical Technologies and Services Europe, as well as General Manager of a manufacturing site.
Pierre holds a PhD in Pharmacy.
Matthew Wilder, VP US Sales and Marketing, joins NextPharma with over ten years of sales and marketing experience in the US pharmaceutical industry. Prior to joining NextPharma, Matthew spent over ten years with Sanofi Pharmaceuticals, where he held various senior positions including Divisional Sales Manager and Regional Sales Director.
Matthew holds a degree in Marketing